Drug intelligence / Profile preview

siATP5G3

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intracellular
01

Overview

siATP5G3 is a small interfering RNA (siRNA) that targets the mRNA of the ATP5G3 gene, which encodes subunit C3 of the mitochondrial ATP synthase complex (Complex V). By silencing ATP5G3 expression, this agent is used in research to investigate mitochondrial function and cell death pathways. In cervical carcinoma (HeLa) cell models, siATP5G3-mediated knockdown has been shown to enhance cytotoxicity induced by sodium nitroprusside (SNP). This effect is mediated through the activation of the p38 MAPK signaling pathway and the subsequent modulation of pro-apoptotic and anti-apoptotic proteins like Bax and Bcl-xL, leading to autophagic or lysosome-associated cell death. It serves as a research tool to demonstrate the protective role of ATP5G3 against oxidative stress-induced cell death.

Other names
ATP5G3 siRNAATP-5G3 siRNAATP 5G3 siRNAsmall interfering RNA targeting ATP5G3
02

Targets

p3 (Amyloid-beta p3 fragment)

Beyond the preview

Go deeper on siATP5G3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on siATP5G3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call